Harvey A. Risch

Harvey A. Risch's AcademicInfluence.com Rankings

Harvey A. Risch

Medical

#2182

World Rank

#2586

Historical Rank

Epidemiology

#369

World Rank

#388

Historical Rank

medical Degrees

Download Badge

Medical

Harvey A. Risch's Degrees

Doctorate Medicine University of California, San Diego
PhD Epidemiology University of California, San Diego

Why Is Harvey A. Risch Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Harvey A. Risch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. (2003) (3543)
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. (2001) (1035)
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. (2003) (934)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (2015) (838)
Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. (1999) (799)
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies (2012) (738)
Population attributable risks of esophageal and gastric cancers. (2003) (714)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. (2006) (666)
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. (1998) (630)
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer (2009) (618)
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. (1997) (616)
Type I and II endometrial cancers: have they different risk factors? (2013) (597)
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer (1998) (597)
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. (1998) (550)
An application of capture-recapture methods to the estimation of completeness of cancer registration. (1988) (547)
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 (2010) (542)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
Detectable clonal mosaicism and its relationship to aging and cancer (2012) (512)
Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. (1993) (474)
Nutrient intake and risk of subtypes of esophageal and gastric cancer. (2001) (456)
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. (1998) (442)
Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. (2002) (424)
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions (2008) (403)
Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. (1989) (390)
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. (2011) (371)
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer (2013) (350)
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 (2010) (341)
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. (2000) (321)
Dietary factors and the incidence of cancer of the stomach. (1985) (312)
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). (2012) (312)
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 (2009) (305)
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study (2017) (302)
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. (2010) (285)
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer (2014) (273)
Parity, contraception, infertility, and the risk of epithelial ovarian cancer. (1994) (266)
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. (2007) (266)
Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. (1996) (266)
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. (2007) (243)
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium (2012) (232)
Changing incidence of thyroid cancer. (2006) (231)
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer (2000) (223)
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer (2015) (210)
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. (2014) (187)
Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies (2012) (182)
Risk of bladder cancer by source and type of tobacco exposure: A case‐control study (1989) (182)
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. (2013) (180)
A Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett’s Esophagus (2013) (179)
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus (2012) (176)
Identification of six new susceptibility loci for invasive epithelial ovarian cancer (2014) (176)
An exploratory case-control study of brain tumors in adults. (1987) (175)
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. (1998) (171)
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer (2013) (167)
Pelvic inflammatory disease and the risk of epithelial ovarian cancer. (1995) (165)
Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. (2004) (163)
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). (2012) (159)
Risk factors for spontaneous abortion and its recurrence. (1988) (158)
ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. (2010) (157)
Events of reproductive life and the incidence of epithelial ovarian cancer. (1983) (155)
Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. (2012) (155)
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. (2013) (155)
Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer (2012) (154)
Dietary factors and the incidence of cancer of the urinary bladder. (1988) (150)
An exploratory case-control study of brain tumors in children. (1989) (149)
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies (2005) (149)
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
Dietary fat intake and risk of epithelial ovarian cancer. (1994) (146)
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer (2018) (146)
Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. (2014) (142)
Family history of cancer and risk of esophageal and gastric cancers in the United States (2001) (141)
Gastroesophageal Reflux in Relation to Adenocarcinomas of the Esophagus: A Pooled Analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON) (2014) (141)
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. (2015) (133)
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2. (2013) (128)
Identification of nine new susceptibility loci for endometrial cancer (2018) (122)
Histopathologic Features of Genetically Determined Ovarian Cancer (2002) (120)
Food group intake and risk of subtypes of esophageal and gastric cancer (2008) (119)
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. (1998) (117)
An Absolute Risk Model to Identify Individuals at Elevated Risk for Pancreatic Cancer in the General Population (2013) (116)
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis (2016) (115)
Dietary factors and risk of lung cancer: Results from a case‐control study, toronto, 1981–1985 (1990) (115)
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions (2008) (112)
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. (2012) (111)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 (2013) (110)
Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. (1997) (107)
Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium (2011) (106)
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium (2015) (104)
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection (2020) (102)
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. (2013) (100)
Estrogen replacement therapy and risk of epithelial ovarian cancer. (1996) (97)
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. (2016) (96)
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies (2013) (95)
Occupational factors and the incidence of cancer of the bladder in Canada. (1988) (94)
Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus (2015) (93)
Characterization of large structural genetic mosaicism in human autosomes. (2015) (91)
Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status. (2016) (89)
Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis (2020) (89)
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. (2016) (87)
Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. (2006) (85)
IGF-I in epithelial ovarian cancer and its role in disease progression (2007) (85)
ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. (2013) (83)
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 (2016) (83)
Hereditary and familial ovarian cancer in southern ontario (1994) (83)
Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data (2016) (83)
Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. (2005) (83)
Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer. (2011) (83)
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. (2011) (82)
Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1 (2012) (82)
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). (2012) (81)
Genome-wide significant risk associations for mucinous ovarian carcinoma (2015) (81)
Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls (2013) (80)
Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer (2015) (80)
Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study. (1995) (78)
The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. (2012) (78)
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations (2012) (76)
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). (2011) (75)
The Healthy Eating Index 2005 and risk for pancreatic cancer in the NIH-AARP study. (2013) (75)
Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA) (2015) (75)
Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. (2011) (74)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
Pancreatic cancer: Helicobacter pylori colonization, N‐Nitrosamine exposures, and ABO blood group (2012) (73)
Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis (2015) (73)
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome (2016) (72)
Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer (2012) (71)
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations (1999) (71)
Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. (1994) (71)
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (2017) (70)
Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome (2011) (70)
Case–Control Study of Aspirin Use and Risk of Pancreatic Cancer (2014) (69)
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. (2015) (68)
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). (2020) (68)
GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. (2007) (68)
Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. (2012) (68)
Multiple births and risk of epithelial ovarian cancer. (2000) (67)
The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer. (2006) (67)
Shared heritability and functional enrichment across six solid cancers (2018) (67)
Perineal talc exposure and risk of ovarian carcinoma (1997) (66)
Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk (2011) (66)
PGR +331 A/G and Increased Risk of Epithelial Ovarian Cancer (2006) (66)
Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis (2016) (65)
Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer (2014) (61)
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies (2017) (60)
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. (2016) (60)
Intrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium (2014) (60)
Abortion and its effect on risk of preeclampsia and transient hypertension. (2000) (60)
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants (2020) (60)
Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis (2015) (60)
Helicobacter pylori Seropositivities and Risk of Pancreatic Carcinoma (2013) (59)
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis (2008) (59)
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancers: classification tree analysis. (2014) (58)
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. (2010) (57)
Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. (2017) (56)
The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing (2011) (56)
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. (2001) (55)
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers (2019) (55)
Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study. (2009) (55)
LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer (2015) (54)
TERT gene harbors multiple variants associated with pancreatic cancer susceptibility (2015) (54)
Aspirin Use and Reduced Risk of Pancreatic Cancer (2016) (54)
CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations (2009) (54)
Long‐term overweight and weight gain in early adulthood in association with risk of endometrial cancer (2011) (53)
Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma (2008) (53)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. (2015) (53)
Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer (2017) (53)
Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer (2013) (52)
Molecular Markers and Death From Prostate Cancer (2009) (51)
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer (2015) (50)
Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2) (2015) (49)
Association Between Breastfeeding and Ovarian Cancer Risk. (2020) (49)
Changes in breast self‐examination behavior in a cohort of 8214 women in the Canadian national breast screening study (1986) (48)
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations. (1999) (46)
Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer. (2016) (45)
Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression (2009) (45)
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. (2018) (45)
Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer. (2012) (45)
Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. (2014) (45)
A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. (2020) (45)
Carbonated soft drink consumption and risk of esophageal adenocarcinoma. (2006) (44)
Omega-3 and omega-6 fatty acid intakes and endometrial cancer risk in a population-based case–control study (2013) (44)
Age‐specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium (2016) (43)
The Smoke Ring: Tobacco, Money and Multinational Politics (1985) (42)
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. (2014) (42)
Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium. (2017) (42)
Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium (2016) (41)
Risk of hospitalization for Covid-19 outpatients treated with various drug regimens in Brazil: Comparative analysis (2020) (41)
Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study (2018) (40)
Genome-wide association study of endometrial cancer in E2C2 (2013) (40)
Genome-Wide Association Study Identifies a Possible Susceptibility Locus for Endometrial Cancer (2012) (39)
Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study (2019) (38)
Cigarette smoking and pancreatic cancer risk: more to the story than just pack-years. (2014) (38)
Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. (2014) (38)
Green tea drinking and risk of pancreatic cancer: a large-scale, population-based case-control study in urban Shanghai. (2012) (38)
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 (2017) (37)
Molecular markers and mortality in prostate cancer (2007) (37)
Quantifying the Genetic Correlation between Multiple Cancer Types (2017) (37)
Randomized Trial of Exercise on Quality of Life in Women With Ovarian Cancer: Women’s Activity and Lifestyle Study in Connecticut (WALC) (2017) (37)
Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D1 (2004) (36)
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk (2015) (36)
Meat consumption and risk of incident dementia: cohort study of 493,888 UK Biobank participants (2021) (36)
Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases (2019) (35)
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium (2013) (35)
Exosomes: potential for early detection in pancreatic cancer. (2016) (34)
Current Approaches to Pancreatic Cancer Screening. (2019) (34)
Genes–Environment Interactions in Obesity- and Diabetes-Associated Pancreatic Cancer: A GWAS Data Analysis (2013) (34)
Telomere structure and maintenance gene variants and risk of five cancer types (2016) (34)
Height, weight, BMI and ovarian cancer survival. (2012) (33)
Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada) (1994) (32)
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk (2016) (32)
Occupation and risk of esophageal and gastric cardia adenocarcinoma. (2002) (32)
Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). (2013) (32)
Association between ultraviolet radiation, skin sun sensitivity and risk of pancreatic cancer. (2013) (31)
Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma (2016) (31)
Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium (2016) (30)
Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas (2007) (29)
Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. (2015) (29)
Dietary fat intake and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. (2013) (28)
Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. (2014) (28)
Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk (2015) (28)
Let-7a regulation of insulin-like growth factors in breast cancer (2011) (28)
Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer (2020) (27)
PPM1D mutations in circulating white blood cells and the risk for ovarian cancer. (2014) (27)
Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1. (2008) (27)
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted? (2017) (26)
Occupational exposure to N-nitrosamines and pesticides and risk of pancreatic cancer (2015) (26)
Physical activity and endometrial cancer in a population-based case–control study (2011) (26)
Polymorphisms in Inflammation Pathway Genes and Endometrial Cancer Risk (2012) (26)
History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium (2017) (26)
Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000–2013 (2017) (26)
Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC) (2015) (26)
Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study (2016) (25)
Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis (2020) (25)
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer (2020) (25)
MicroRNA let‐7a modifies the effect of self‐renewal gene HIWI on patient survival of epithelial ovarian cancer (2016) (24)
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA (2013) (24)
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types (2015) (24)
Preventing ovarian cancer through genetic testing: a population‐based study (2014) (24)
Diabetes and Pancreatic Cancer: Both Cause and Effect. (2018) (24)
Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer. (2015) (24)
Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens (2017) (24)
Hormone replacement therapy and the risk of ovarian cancer. (2002) (23)
MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium (2015) (23)
Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies (2017) (23)
A pooled analysis of dietary sugar/carbohydrate intake and esophageal and gastric cardia adenocarcinoma incidence and survival in the USA. (2017) (23)
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. (2018) (23)
Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study (2018) (22)
Telomere Length and Mortality Following a Diagnosis of Ovarian Cancer (2014) (22)
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium (2017) (22)
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States) (2003) (22)
Ovarian cancer, oral contraceptives, and BRCA mutations. (2001) (22)
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes (2016) (22)
Genetic Effects and Modifiers of Radiotherapy and Chemotherapy on Survival in Pancreatic Cancer (2011) (21)
Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk (2015) (21)
GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer. (2016) (21)
The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. (2016) (21)
A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus (2015) (20)
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas (2009) (20)
Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study (2020) (20)
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci (2017) (19)
MicroRNA Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium (2011) (19)
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. (2018) (18)
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. (2018) (18)
Factors associated with psychological resilience in left-behind children in southwest China. (2019) (18)
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. (2016) (18)
Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia. (2014) (18)
Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer (2019) (17)
Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer (2016) (17)
Frequency of germline PALB2 mutations among women with epithelial ovarian cancer (2016) (17)
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium (2017) (17)
Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case–control study (2016) (17)
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. (2015) (17)
Association between family cancer history and risk of pancreatic cancer. (2016) (17)
Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer. (2014) (16)
Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk (2019) (16)
LIN 28 B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer (2011) (16)
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
Use of aspirin, other nonsteroidal anti-inflammatory drugs and acetaminophen and risk of endometrial cancer: the Epidemiology of Endometrial Cancer Consortium (2019) (16)
Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data (2019) (15)
Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. (2019) (15)
Re: Are women more susceptible to lung cancer? (2004) (15)
Dietary energy density is positively associated with risk of pancreatic cancer in urban Shanghai Chinese. (2013) (15)
Risk Factors for Ovarian Cancers With and Without Microsatellite Instability (2014) (15)
Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer (2011) (15)
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers (2019) (15)
Canadian National Breast Screening Study: first screen results as predictors of future breast cancer risk. (1993) (15)
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes (2011) (15)
Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortality. (2011) (15)
Polymorphisms Near TBX 5 and GDF 7 Are Associated With Increased Risk for Barrett ’ s Esophagus (14)
Germline Copy Number Variation and Ovarian Cancer Survival (2012) (14)
Genome-wide association study of endometrial cancer in E 2 C 2 (2014) (14)
Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population (2014) (14)
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17 q 21 . 31 (2013) (14)
Flavonoid intake and risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study Cohort (2012) (14)
Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus (2018) (13)
Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case–Control Consortium (PanC4) (2016) (13)
Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium (2019) (13)
Joint Effect of Genotypic and Phenotypic Features of Reproductive Factors on Endometrial Cancer Risk (2015) (13)
Lung cancer risk for female smokers. (1994) (13)
Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study (2018) (13)
Reporting and guidelines for mendelian randomization analysis: A systematic review of oncological studies. (2019) (13)
Evaluation of Association of HNF 1 B Variants with Diverse Cancers : Collaborative Analysis of Data from 19 Genome-Wide Association Studies (2010) (12)
Lung cancer in women in the Niagara Region, Ontario: a case-control study. (1991) (12)
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. (2020) (12)
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study (2018) (12)
Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. (2016) (12)
Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas (2001) (12)
Urinary Prostaglandin E2 Metabolite and Pancreatic Cancer Risk: Case-Control Study in Urban Shanghai (2015) (12)
No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. (2019) (12)
Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer (2020) (12)
Prognostic and predictive values of long non-coding RNA LINC 00472 in breast cancer (2015) (12)
Use of aspirin, other nonsteroidal anti-inflammatory drugs and acetaminophen and risk of endometrial cancer: the Epidemiology of Endometrial Cancer Consortium. (2019) (12)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (11)
Exome-Wide Association Study of Endometrial Cancer in a Multiethnic Population (2014) (11)
Self-harm behaviors, suicidal ideation, and associated factors among rural left-behind children in west China. (2020) (11)
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. (2014) (11)
LIN-28B/let-7a/IGF-II axis molecular subtypes are associated with epithelial ovarian cancer prognosis. (2016) (11)
Lymphocyte micronuclei and sister chromatid exchanges among Canadian federal laboratory employees. (1988) (11)
The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant (2021) (10)
A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status (2004) (10)
Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium (2018) (10)
Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk (2020) (10)
Body Mass Index Genetic Risk Score and Endometrial Cancer Risk (2015) (10)
Excess diagnosis of non-Hodgkin's lymphoma during spring in the USA (2007) (10)
Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma (2016) (10)
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration (2016) (10)
Re: On the use of familial aggregation in population-based case probands for calculating penetrance. (2003) (10)
Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett’s Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium (2015) (9)
Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence (2018) (9)
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility (2018) (9)
The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancer. (2003) (9)
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
Randomized trial of exercise on quality of life and fatigue in women diagnosed with ovarian cancer: The Women’s Activity and Lifestyle Study in Connecticut (WALC). (2015) (9)
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium (2017) (8)
Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome‐wide association study (2021) (8)
Polymorphic Variation of Genes in the Fibrinolytic System and the Risk of Ovarian Cancer (2009) (8)
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer (2020) (8)
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. (2018) (8)
Pleiotropic Analysis of Cancer Risk Loci on Esophageal Adenocarcinoma Risk (2015) (8)
Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. (2020) (8)
Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D1: A Population-Based Study (2004) (8)
Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. (2019) (8)
Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (2020) (8)
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents (2021) (7)
Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews (2017) (7)
Re: Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. (1997) (7)
Response to: “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients” and “Re: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis” (2020) (7)
A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. (2021) (7)
Dietary flavonoid intake and Barrett's esophagus in western Washington State. (2015) (7)
A Resequence Analysis of Genomic Loci on Chromosomes 1q32.1, 5p15.33, and 13q22.1 Associated With Pancreatic Cancer Risk (2013) (7)
Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3 (2021) (6)
The age-dependent association of risk factors with pancreatic cancer. (2022) (6)
A GEM-TPC in twin configuration for the Super-FRS tracking of heavy ions at FAIR (2018) (6)
Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies. (2020) (6)
Risch Responds to “How to Consider Low Reported Death Rates in COVID-19” (2020) (6)
Hepcidin-regulating Iron-metabolism Genes and Pancreatic Ductal Adenocarcinoma: A Pathway Analysis of Genome-wide Association Studies (2020) (6)
Consumption of precursors of N-nitroso compounds and human gastric cancer. (1987) (6)
Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D 1 : A Population-Based Study (2004) (6)
Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk (2020) (6)
Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations (2020) (6)
Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. (2020) (6)
corrigenda to Vitamin D and pancreatic cancer: A pooled analysis from the pancreatic cancer case-control consortium [Ann Oncol 2015; 26: 1776-1783 (doi: 10.1093/annonc/mdv236)] (2016) (5)
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer (2020) (5)
A Population-Based Case-Control Study of Occupational Exposure to Acids and the Risk of Lung Cancer: Evidence for Specificity of Association (2011) (5)
Risk Factors for Ovarian Cancers With and Without Microsatellite Instability (2013) (5)
Re: "Polychotomous logistic regression methods for matched case-control studies with multiple case or control groups". (1988) (5)
Accumulation of p 53 protein is frequent in ovarian cancers associated with BRCA 1 and BRCA 2 germline mutations (1999) (5)
Genome-Wide Gene–Diabetes and Gene–Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia (2020) (5)
Response to: Comment on “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients That Should be Ramped-Up Immediately as Key to the Pandemic Crisis” (2020) (5)
Two-Sample Mendelian Randomization Analysis of Associations Between Periodontal Disease and Risk of Cancer (2021) (4)
Survival in women with ovarian cancer with and without microsatellite instability. (2015) (4)
Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4 (2013) (4)
Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk (2020) (4)
An approximate solution for the standard deterministic epidemic model (1983) (4)
European American Stratification in Ovarian Cancer Case Control Data: The Utility of Genome-Wide Data for Inferring Ancestry (2012) (4)
RESPONSE: Re: Multiple Births and Risk of Epithelial Ovarian Cancer (2001) (4)
Re: sex, smoking, and cancer: a reappraisal. (2002) (4)
Randomized trial of exercise on depressive symptomatology and brain derived neurotrophic factor (BDNF) in ovarian cancer survivors: The Women's Activity and Lifestyle Study in Connecticut (WALC). (2021) (4)
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018) (4)
Oral-contraceptive use, anovulatory action, and risk of epithelial ovarian cancer. (2000) (4)
Diet and lung cancer. (1989) (4)
Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. (2021) (3)
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer (2016) (3)
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium (2017) (3)
Oral Cyanobacteria and Hepatocellular Carcinoma (2021) (3)
Ovarian cancer survival by tumor dominance, a surrogate for site of origin (2015) (3)
Short Communication PGR + 331 A / G and Increased Risk of Epithelial Ovarian Cancer (2006) (3)
A New Estimation Approach for Combining Epidemiological Data From Multiple Sources (2014) (3)
Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus. (2016) (3)
Low-Dose Aspirin and Pancreatic Cancer Risk—Reply (2017) (3)
An association between a variation in the PSCA gene and upper gastrointestinal cancer in Caucasians (2011) (2)
Re: Cancer risks in BRCA1 carriers: time for the next generation of studies. (2003) (2)
Changing incidence of thyroid cancer. Authors' reply (2006) (2)
Polymorphisms in In fl ammation Pathway Genes and Endometrial Cancer Risk (2013) (2)
Common variants at the CHEK 2 gene locus and risk of epithelial ovarian cancer (2015) (2)
A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population (2020) (2)
History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium (2017) (2)
Comment on: Are women more susceptible to lung cancer? Author's reply (2004) (2)
Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study (2020) (2)
Original Article Associations of LIN-28B/let-7a/IGF-II axis haplotypes with disease survival in epithelial ovarian cancer (2015) (2)
Smoking and ovarian cancer (2010) (2)
Comment on: Carbonated soft drink consumption and risk of esophageal adenocarcinoma. Authors' reply (2006) (2)
Reply to Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? (2011) (2)
Prediction of Pancreatic Cancer in Diabetes Patients with Worsening Glycemic Control (2021) (2)
Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium (2018) (2)
The Bundeskriminalamt: The German Federal Criminal Police Office (1991) (2)
Role of hydroxychloroquine in multidrug treatment of COVID-19. (2021) (2)
Abstract 633: Synergistic interplay between long-term overweight and long menstrual years in endometrial cancer (2012) (2)
Correction: Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk (2015) (2)
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study (2018) (1)
Aspirin and Pancreatic Cancer—Response (2017) (1)
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. (2015) (1)
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer (2018) (1)
THE FIRST AUTHOR REPLIES (1990) (1)
Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk (2020) (1)
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer (2021) (1)
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (1)
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium (2013) (1)
The N 314 D Polymorphism of Galactose-1-Phosphate Uridyl Transferase Does Not Modify the Risk of Ovarian Cancer (2003) (1)
Re: NSAID Use and Pancreatic Cancer Risk. (2018) (1)
Identification of nine new susceptibility loci for endometrial cancer (2018) (1)
Effects of risk factors for ovarian cancer in women with and without endometriosis (2022) (1)
Abstract 242: Large pathway and gene set analysis of GWAS data identifies novel associations for pancreatic cancer (2018) (1)
Association of KRAS SNP rs61764370 with risk of invasive epithelial ovarian cancer: Implications for clinical testing (2011) (1)
Comment on: On the use of familial aggregation in population-based case probands for calculating penetrance. Authors' reply (2003) (1)
Abstract 3297: Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013 (2017) (1)
Abstract 1029: The association of body mass index with risk of endometrial cancer subtypes: Pooled analysis in E2C2 (2012) (1)
Abstract 640: Breastfeeding pattern and ovarian cancer risk: Results from the Ovarian Cancer Association Consortium (2019) (1)
Abstract 4809: Dietary fat intake and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. (2013) (1)
Abstract 2293: Oligomenorrhea, polycystic ovary syndrome, and risk of ovarian cancer histotypes, evidence from the Ovarian Cancer Association Consortium (2017) (1)
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers (2020) (1)
It's time to accept that intake of dairy foods is not related to risk of ovarian cancer (2006) (1)
KRAS rs61764370 in Epithelial Ovarian Cancer–Response (2011) (1)
Early Multidrug Outpatient Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home Residents (2021) (1)
Systematic Reviews and Meta- and Pooled Analyses ABO Blood Group and Risk of Pancreatic Cancer: A Study in Shanghai and Meta-Analysis (2013) (1)
THE AUTHOR REPLIES (2020) (1)
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. (2023) (1)
Author Correction: Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases (2019) (1)
Response to Weidhaas and Slack re: Comments on "The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implication for clinical testing" (2011) (1)
High mobility group A protein-2 as a tumor cancer diagnostic and prognostic marker: a systematic review and meta-analysis (2020) (1)
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case–control studies (2020) (1)
Response to: “Overcoming the therapeutic nihilism of out-of-hospital management of COVID-19 patients” (2020) (0)
Alcohol intake and risk of oesophageal adenocarcinoma a pooled analysis from the BEACON Constortium (2018) (0)
Epidemiological study of risk factors for gastric carcinoids (2001) (0)
Abstract 3498: Ovarian cancer risk factors multiply to create high risk in pre-menopausal women (2020) (0)
Randomized trial of exercise vs. usual care on cancer biomarkers in ovarian cancer survivors: The Women’s Activity and Lifestyle Study in Connecticut (WALC). (2016) (0)
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies (2013) (0)
Prevention and Epidemiology LIN 28 B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer (2011) (0)
Abstract A27: Timing of pregnancies and oral contraceptive use and risk of ovarian cancer (2017) (0)
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
T2009 Assessment of Novel Genetic Polymorphisms and Risk of Upper Gastrointestinal Carcinoma (2010) (0)
Short Communication The N314D Polymorphism of Galactose-1-Phosphate Uridyl Transferase Does Not Modify the Risk of Ovarian Cancer (2003) (0)
Abstract 5891: The age-dependent association of risk factors with pancreatic cancer (2022) (0)
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival (2021) (0)
Abstract 1213: Genome-wide interaction scan identifies gene by smoking interaction at 2q21.3 for pancreatic cancer risk (2020) (0)
Helicobacter pylori, gastroesophageal reflux, their interrelationships, and the risk of esophageal adenocarcinoma (2001) (0)
Title Use of common analgesic medications and ovarian cancer survival : results from a pooled analysis in the Ovarian Cancer Association Consortium Permalink (2017) (0)
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA (2013) (0)
Abstract 4729: Pathway and gene set analyses for epithelial ovarian cancer (EOC) genome-wide association study (GWAS) (2011) (0)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
In Memoriam: Sholom Wacholder, PhD. (2015) (0)
Pathologic characteristics of pancreatic cancer in Shanghai urban area:preliminary analysis of 350 cases (2012) (0)
Large scale meta-analysis identifies new genetic risk loci for esophageal adenocarcinoma (EA) and the first EA risk locus independent of Barrett’s esophagus (2017) (0)
Abstract 2835: Mitochondrial genetic variants influence ovarian cancer risk (2010) (0)
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes (2016) (0)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
Abstract 3655: Stem cell-associated gene Lin-28B genotype and phenotype in epithelial ovarian cancer and their associations with disease survival outcomes (2012) (0)
Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis. (2022) (0)
Frequency of germline PALB2 mutations among women with epithelial ovarian cancer (2016) (0)
Systematic Reviews and Meta- and Pooled Analyses Pelvic In ﬂ ammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies (2016) (0)
Likelihood-ratio testing as a diagnostic method for small-sample regression. (1992) (0)
Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case–control study (2016) (0)
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
Abstract B32: Are ovarian cancer risk factors different for women with endometriosis? (2020) (0)
Abstract 1649: Genome-wide association study of copy number variations in serous epithelial ovarian cancer susceptibility (2012) (0)
Two-sample Mendelian randomization analysis of associations between periodontal disease and risk of colorectal, lung, and pancreatic cancers (2021) (0)
Common variants at theCHEK2gene locus and risk of epithelial ovarian cancer (2015) (0)
A Case-control Study of Environmental and Genetic Risk Factors for Pancreatic Carcinoma (2006) (0)
Abstract 4724: A novel region on 8q24.21 is associated with ovarian cancer susceptibility (2010) (0)
Etiologic Mechanisms in Epithelial Ovarian Cancer (2001) (0)
Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis (2015) (0)
OC-052 Assessment of novel genetic polymorphisms and risk of upper gastrointestinal carcinoma (2010) (0)
Infertility, but not fertility drug use, was associated with an increased risk of ovarian cancer (2003) (0)
long- t erm Ov arian cancer Sur vival Associated With Mutation in Brc A1 or B rc A2 (2012) (0)
Abstract 1678: European ancestry and ovarian cancer: Testing for their association using case control data (2012) (0)
Cyclin E Overexpression Relates to Ovarian Cancer Histology but not to Risk Factors (2008) (0)
1 LIN 28 B polymorphisms influence susceptibility to epithelial ovarian cancer (2011) (0)
Bayesian copy number detection and association in large-scale studies (2020) (0)
BASIC AND TRANSLATIONAL—ALIMENTARY TRACT Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus (2015) (0)
Abstract ED02-03: Gene, environment, and risk factor interaction in pancreatic cancer (2010) (0)
Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". (2015) (0)
Comment on: Sex, smoking, and cancer: a reappraisal. Authors' reply (2002) (0)
Abstract 2214: Genome-wide gene-diabetes and gene-obesity interaction scan in the pancreatic cancer case control consortium (2014) (0)
Abstract 61: Genetic pathways related to vitamin D and risk of pancreatic cancer. (2012) (0)
Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancer (2022) (0)
Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions. (2023) (0)
Abstract B70: Physical activity and BMI in a population-based case-control study of endometrial cancer risk (2010) (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
Abstract 1326: A pooled genome-wide association study of pancreatic cancer susceptibility loci in American Jews (2017) (0)
Abstract B21:BRCAmutation status is not associated with better long-term survival from epithelial ovarian cancer. (2016) (0)
Abstract IA-11: An exception to the rule: A coding functional variant at a pancreatic cancer GWAS locus (2020) (0)
Genome-wide association study of endometrial cancer in E2C2 access benefits you. Your story matters (2014) (0)
A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population (2020) (0)
Reproductive factors do not influence survival with ovarian cancer. (2022) (0)
Shared heritability and functional enrichment across six solid cancers (2019) (0)
Associations of LIN-28 B / let-7 a / IGF-II axis haplotypes with disease survival in epithelial ovarian cancer (2015) (0)
THE QUEENSLAND PANCREATIC CANCER STUDY-IDENTIFYING RISK FACTORS FOR PANCREATIC CANCER (2008) (0)
Mo1372 – Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductual Adenocarcinoma: A Pathway Analysis of Genome-Wide Association Studies (2019) (0)
MOLECULAR MARKERS AND LONG-TERM PROGNOSIS IN PROSTATE CANCER (2009) (0)
Genome-wide association study of endometrial cancer in E2C2 (2013) (0)
Abstract 2167: Infertility and risk of incident endometrial carcinoma: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (2014) (0)
Incorporating multiple sets of eQTL weights into gene‐by‐environment interaction analysis identifies novel susceptibility loci for pancreatic cancer (2020) (0)
Risk prediction models for endometrial cancer: development and validation in an international consortium. (2023) (0)
Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4 (2013) (0)
Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study (2012) (0)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
Cross-cancer genome-wide association analysis of lung, ovary, breast, prostate and colon cancer identifies a novel cancer locus at 1q22 (2015) (0)
population based studies 6174delT mutations: a combined analysis of 22 BRCA1 5382insC and 185delAG and BRCA2 Breast and ovarian cancer risks to carriers of the (2006) (0)
Measuring tumor induction period in case control studies of chronic exposures (1986) (0)
Nutrient Intake and Risk of Subtypes of Esophageal and Gastric Cancer 1 (2001) (0)
Ovarian cancer survival by tumor dominance, a surrogate for site of origin (2015) (0)
Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens (2017) (0)
ORAL CONTRACEPTIVES AND THE RISK OF OVARIAN CANCER (1999) (0)
Abstract 14: Body mass index and type 2 diabetes genetic risk scores and endometrial cancer risk among women of European ancestry. (2012) (0)
Abstract 1200: Associations between genetically predicted blood protein biomarkers and pancreatic ductal adenocarcinoma risk (2020) (0)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
Abstract 4668: Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer (2011) (0)
A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization (2021) (0)
Dynamic changes of circulating soluble PD-1/PD-L1 and its association with patient survival in immune checkpoint blockade-treated melanoma. (2023) (0)
Abstract 1295: Genomewide gene-diabetes and gene-obesity interaction scan in 7095 cases and 10710 controls from Pancreatic Cancer Cohort Consortium and Pancreatic Cancer Case Control Consortium (2017) (0)
eQTL set-based association analysis identifies novel susceptibility loci for Barrett's esophagus and esophageal adenocarcinoma. (2022) (0)
Trial of exercise in ovarian cancer survivors. (2012) (0)
University of Birmingham Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus (0)
Abstract 5906: Epidemiologic risk factors and survival trajectories among epithelial ovarian cancer survivors: A population-based cohort study (2022) (0)
A Pathway Analysis of Hereditary Hemochromatosis-related Genes and Pancreatic Ductal Adenocarcinoma Risk (FS11-05-19). (2019) (0)
Postmenopausal estrogen-only, but not estrogen + progestin, was associated with an increased risk of ovarian cancer (2003) (0)
RESPONSE: Re: Carbonated Soft Drink Consumption and Risk of Esophageal Adenocarcinoma (2006) (0)
Comment on: Cancer risks in BRCA1 carriers: Time for the next generation of studies by Gruber SB et al. (2003) (0)
Title Obesity and survival among women with ovarian cancer : Results from the Ovarian Cancer Association Consortium Permalink (2015) (0)
Bayesian copy number detection and association in large-scale studies (2020) (0)
Occupational factors andtheincidence ofcancerof thebladder inCanada (1988) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Harvey A. Risch?

Harvey A. Risch is affiliated with the following schools:

University of Bergen
Yale University
University of California, San Diego
University of South Florida
University of Brescia
University of Toronto
University of Copenhagen
University of Connecticut
Fudan University
University of Cambridge